首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   51878篇
  免费   8472篇
  国内免费   197篇
耳鼻咽喉   1147篇
儿科学   1866篇
妇产科学   1694篇
基础医学   4581篇
口腔科学   3459篇
临床医学   6843篇
内科学   12259篇
皮肤病学   1189篇
神经病学   5035篇
特种医学   1960篇
外国民族医学   3篇
外科学   7619篇
综合类   586篇
现状与发展   12篇
一般理论   43篇
预防医学   4954篇
眼科学   947篇
药学   1938篇
中国医学   14篇
肿瘤学   4398篇
  2023年   1164篇
  2022年   476篇
  2021年   1021篇
  2020年   1469篇
  2019年   921篇
  2018年   1806篇
  2017年   1626篇
  2016年   1885篇
  2015年   1995篇
  2014年   2575篇
  2013年   3307篇
  2012年   2003篇
  2011年   2036篇
  2010年   2117篇
  2009年   2596篇
  2008年   1927篇
  2007年   1774篇
  2006年   1921篇
  2005年   1663篇
  2004年   1537篇
  2003年   1396篇
  2002年   1429篇
  2001年   1467篇
  2000年   1435篇
  1999年   1354篇
  1998年   858篇
  1997年   785篇
  1996年   849篇
  1995年   679篇
  1994年   587篇
  1993年   559篇
  1992年   1032篇
  1991年   952篇
  1990年   818篇
  1989年   868篇
  1988年   794篇
  1987年   825篇
  1986年   745篇
  1985年   766篇
  1984年   610篇
  1983年   553篇
  1982年   381篇
  1981年   295篇
  1980年   303篇
  1979年   488篇
  1978年   337篇
  1977年   300篇
  1976年   311篇
  1974年   320篇
  1973年   310篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed.  相似文献   
5.
6.
7.

Background

Payers frequently rely on budget impact model (BIM) results to help determine drug coverage policy and its effect on their bottom line. It is unclear whether BIMs typically overestimate or underestimate real-world budget impact.

Objective

We examined how different modeling assumptions influenced the results of 6 BIMs from the Institute for Clinical and Economic Review (ICER).

Study Design

Retrospective analysis of pharmaceutical sales data.

Methods

From ICER reports issued before 2016, we collected estimates of 3 BIM outputs: aggregate therapy cost (ie, cost to treat the patient population with a particular therapy), therapy uptake, and price. We compared these against real-world estimates that we generated using drug sales data. We considered 2 classes of BIM estimates: those forecasting future uptake of new agents, which assumed “unmanaged uptake,” and those describing the contemporaneous market state (ie, estimates of current, managed uptake and budget impact for compounds already on the market).

Results

Differences between ICER's estimates and our own were largest for forecasted studies. Here, ICER's uptake estimates exceeded real-world estimates by factors ranging from 7.4 (sacubitril/valsartan) to 54 (hepatitis C treatments). The “unmanaged uptake” assumption (removed from ICER's approach in 2017) yields large deviations between BIM estimates and real-world consumption. Nevertheless, in some cases, ICER's BIMs that relied on current market estimates also deviated substantially from real-world sales data.

Conclusions

This study highlights challenges with forecasting budget impact. In particular, assumptions about uptake and data source selection can greatly influence the accuracy of results.  相似文献   
8.

Introduction

Physician communication impacts patient outcomes. However, communication skills, especially around difficult conversations, remain suboptimal, and there is no clear way to determine the validity of entrustment decisions. The aims of this study were to 1) describe the development of a simulation-based mastery learning (SBML) curriculum for breaking bad news (BBN) conversation skills and 2) set a defensible minimum passing standard (MPS) to ensure uniform skill acquisition among learners.

Innovation

An SBML BBN curriculum was developed for fourth-year medical students. An assessment tool was created to evaluate the acquisition of skills involved in a BBN conversation. Pilot testing was completed to confirm improvement in skill acquisition and set the MPS.

Outcomes

A BBN assessment tool containing a 15-item checklist and six scaled items was developed. Students' checklist performance improved significantly at post-test compared to baseline (mean 65.33%, SD = 12.09% vs mean 88.67%, SD = 9.45%, P < 0.001). Students were also significantly more likely to have at least a score of 4 (on a five-point scale) for the six scaled questions at post-test. The MPS was set at 80%, requiring a score of 12 items on the checklist and at least 4 of 5 for each scaled item. Using the MPS, 30% of students would require additional training after post-testing.

Comments

We developed a SBML curriculum with a comprehensive assessment of BBN skills and a defensible competency standard. Future efforts will expand the mastery model to larger cohorts and assess the impact of rigorous education on patient care outcomes.  相似文献   
9.
10.
We present the case of 7‐year‐old African American girl with loose anagen syndrome. Although this is a common cause of hair loss in Caucasian children, and there have been reports of cases occurring in dark‐skinned children of North African and Middle Eastern descent, to our knowledge there have been no cases reported in black children of sub‐Saharan African ancestry. We present this case to broaden the differential diagnosis of hair loss in African Americans.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号